Regional diffusion imaging measures to disentangle SVD-related hypertensive arteriopathy versus cerebral amyloid angiopathy
Sheelakumari Raghavan(Mayo Clinic), for the Alzheimer’s Disease Neuroimaging Initiative, Aivi T. Nguyen(Mayo Clinic), Audrey Low(WinnMed), Michael G. Kamykowski(Mayo Clinic), Angela J. Fought(Mayo Clinic in Florida), Heather J. Wiste(Mayo Clinic in Florida), B. Gwen Windham(University of Mississippi Medical Center), Clifford R. Jr Jack(Mayo Clinic), Melissa E. Murray(Mayo Clinic in Florida), Jonathan Graff-Radford(Mayo Clinic), Val J. Lowe(Mayo Clinic), Prashanthi Vemuri(Mayo Clinic), Robert. I. Reid(WinnMed), Ronald C. Petersen(Mayo Clinic), Scott A. Przybelski(Mayo Clinic in Florida), Mingzhao Hu(Mayo Clinic in Florida), Robel K Gebre(Mayo Clinic)
Cited by 0
Related Papers
Amyloid and tau PET-positive cognitively unimpaired individuals are at high risk for future cognitive decline
|Nature Medicine|2022|483
Amyloid-β deposition and regional grey matter atrophy rates in dementia with Lewy bodies
|Brain|2016|87
Plasma p-tau217 and tau-PET predict future cognitive decline among cognitively unimpaired individuals: implications for clinical trials
|Nature Aging|2025|68
An investigation of cerebrovascular lesions in dementia with Lewy bodies compared to Alzheimer's disease
|Alzheimer s & Dementia|2016|60
Preparation of filter by alkali activation of blast furnace slag and its application for dye removal
|Journal of environmental chemical engineering|2021|42